From: An integrative analysis reveals cancer risk associated with artificial sweeteners
Cohort | Full name |
---|---|
TCGA-ACC | Adrenocortical carcinoma |
TCGA-BLCA | Bladder Urothelial Carcinoma |
TCGA-BRCA | Breast invasive carcinoma |
TCGA-CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
TCGA-CHOL | Cholangiocarcinoma |
TCGA-COAD | Colon adenocarcinoma |
TCGA-DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
TCGA-ESCA | Esophageal carcinoma |
TCGA-GBM | Glioblastoma multiforme |
TCGA-HNSC | Head and Neck squamous cell carcinoma |
TCGA-KICH | Kidney Chromophobe |
TCGA-KIRC | Kidney renal clear cell carcinoma |
TCGA-KIRP | Kidney renal papillary cell carcinoma |
TCGA-LAML | Acute Myeloid Leukemia |
TCGA-LGG | Brain Lower Grade Glioma |
TCGA-LIHC | Liver hepatocellular carcinoma |
TCGA-LUAD | Lung adenocarcinoma |
TCGA-LUSC | Lung squamous cell carcinoma |
TCGA-MESO | Mesothelioma |
TCGA-OV | Ovarian serous cystadenocarcinoma |
TCGA-PAAD | Pancreatic adenocarcinoma |
TCGA-PCPG | Pheochromocytoma and Paraganglioma |
TCGA-PRAD | Prostate adenocarcinoma |
TCGA-READ | Rectum adenocarcinoma |
TCGA-SARC | Sarcoma |
TCGA-STAD | Stomach adenocarcinoma |
TCGA-SKCM | Skin Cutaneous Melanoma |
TCGA-TGCT | Testicular Germ Cell Tumors |
TCGA-THCA | Thyroid carcinoma |
TCGA-THYM | Thymoma |
TCGA-UCEC | Uterine Corpus Endometrial Carcinoma |
TCGA-UCS | Uterine Carcinosarcoma |
TCGA-UVM | Uveal Melanoma |